# CAMX PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/CAMX
Company: Camurus

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with CAMX.

## CAMX PDUFA Milestones

- 2026-06-10 — PDUFA — FDA issued a Complete Response Letter. FDA said the NDA could not be approved until observations from a third-party manufacturer's September 2024 cGMP inspec...
  Company: Camurus
  Source: https://www.camurus.com/media/press-releases/2026/camurus-provides-regulatory-update-on-the-us-nda-for-cam2029-oclaiz-in-acromegaly/
  Event detail: https://biopharmsignal.com/pdufa-calendar/CAMX/oclaiz-acromegaly-review-2.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/june (June 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/CAMX
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the CAMX PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with CAMX, including decision dates, application stage, and summary details when available.
### Where can I find more context for CAMX?

Use the BioPharmSignal company page for CAMX to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.